EGFR Mutation Testing Practices within the Asia Pacific Region: Results of a Multicenter Diagnostic Survey-Reference-Cited by-同舟云学术

EGFR Mutation Testing Practices within the Asia Pacific Region: Results of a Multicenter Diagnostic Survey

Published:2015-03 Issue:3 Volume:10 Page:438-445
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Yatabe Yasushi,Kerr Keith M.,Utomo Ahmad,Rajadurai Pathmanathan,Tran Van Khanh,Du Xiang,Chou Teh-Ying,Enriquez Ma. Luisa D.,Lee Geon Kook,Iqbal Jabed,Shuangshoti Shanop,Chung Jin-Haeng,Hagiwara Koichi,Liang Zhiyong,Normanno Nicola,Park Keunchil,Toyooka Shinichi,Tsai Chun-Ming,Waring Paul,Zhang Li,McCormack Rose,Ratcliffe Marianne,Itoh Yohji,Sugeno Masatoshi,Mok Tony

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference19 articles.

1. Mutation incidence and coincidence in non small-cell lung cancer: Meta-analyses by ethnicity and histology (mutMap);Dearden;Ann Oncol,2013

2. Somatic mutations affect key pathways in lung adenocarcinoma;Ding;Nature,2008

3. New driver mutations in non-small-cell lung cancer;Pao;Lancet Oncol,2011

4. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of ESM1 in the lipids metabolic reprogramming and angiogenesis of lung adenocarcinoma cells;Heliyon;2024-09

2. Isotoosendanin exerts anti-tumor effects in NSCLC by enhancing the stability of SHP-2 and inhibiting the JAK/STAT3 pathway;Phytomedicine;2024-09

3. A phase 2 study of mobocertinib as first-line treatment in Japanese patients with non-small cell lung cancer harboring EGFR exon 20 insertion mutations;International Journal of Clinical Oncology;2024-08-27

4. Discovery of novel EGFR-PROTACs capable of degradation of multiple EGFR-mutated proteins;European Journal of Medicinal Chemistry;2024-06

5. β-Elemene Reverses Gefitinib Resistance in NSCLC Cells by Inhibiting lncRNA H19-Mediated Autophagy;Pharmaceuticals;2024-05-14